Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2026-02-20 @ 7:29 PM
Study NCT ID:
NCT07001995
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-06-03
First Post:
2025-05-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
Sponsor:
Hunan Province Tumor Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-25
First Submit QC Date:
None
Study First Post Date:
2025-06-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-25
Last Update Post Date:
2025-06-03
Last Update Post Date Type:
ACTUAL